Bruker Corporation

NasdaqGS:BRKR 주식 보고서

시가총액: US$8.1b

Bruker 관리

관리 기준 확인 4/4

Bruker CEO는 Frank Laukien, Feb1991 에 임명되었습니다 의 임기는 33.75 년입니다. 총 연간 보상은 $ 5.86M, 15.8% 로 구성됩니다. 15.8% 급여 및 84.2% 보너스(회사 주식 및 옵션 포함). 는 $ 2.15B 가치에 해당하는 회사 주식의 26.55% 직접 소유합니다. 2.15B. 경영진과 이사회의 평균 재임 기간은 각각 10.6 년과 9.3 년입니다.

주요 정보

Frank Laukien

최고 경영자

US$5.9m

총 보상

CEO 급여 비율15.8%
CEO 임기33.8yrs
CEO 소유권26.5%
경영진 평균 재임 기간10.6yrs
이사회 평균 재임 기간9.3yrs

최근 관리 업데이트

Recent updates

Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Nov 14
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Bruker: Still Challenged, Certainly Margins

Nov 02

Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

Oct 25
Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Sep 10
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In

Aug 22

Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 22
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

Jan 22
Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Jan 08
There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Dec 26
Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Nov 06
Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Oct 23
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Sep 25
Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Aug 09
Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 27
Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

Jul 11
Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

CEO 보상 분석

Frank Laukien 의 보수는 Bruker 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

US$305m

Jun 30 2024n/an/a

US$352m

Mar 31 2024n/an/a

US$402m

Dec 31 2023US$6mUS$926k

US$427m

Sep 30 2023n/an/a

US$319m

Jun 30 2023n/an/a

US$319m

Mar 31 2023n/an/a

US$312m

Dec 31 2022US$5mUS$873k

US$297m

Sep 30 2022n/an/a

US$275m

Jun 30 2022n/an/a

US$274m

Mar 31 2022n/an/a

US$282m

Dec 31 2021US$6mUS$812k

US$277m

Sep 30 2021n/an/a

US$270m

Jun 30 2021n/an/a

US$238m

Mar 31 2021n/an/a

US$204m

Dec 31 2020US$4mUS$689k

US$158m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$165m

Mar 31 2020n/an/a

US$177m

Dec 31 2019US$5mUS$753k

US$197m

Sep 30 2019n/an/a

US$207m

Jun 30 2019n/an/a

US$189m

Mar 31 2019n/an/a

US$184m

Dec 31 2018US$4mUS$731k

US$180m

Sep 30 2018n/an/a

US$98m

Jun 30 2018n/an/a

US$92m

Mar 31 2018n/an/a

US$84m

Dec 31 2017US$5mUS$704k

US$79m

보상 대 시장: Frank 의 총 보상 ($USD 5.86M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 7.94M ).

보상과 수익: Frank 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.


CEO

Frank Laukien (64 yo)

33.8yrs

테뉴어

US$5,858,761

보상

Dr. Frank H. Laukien, Ph D., serves as the Chairman, Chief Executive Officer and President of Bruker Corporation at Bruker BioSpin GmbH since February 1991. Dr. Laukien serves as the Chairman, Chief Execut...


리더십 팀

이름위치테뉴어보상소유권
Frank Laukien
Chairman33.8yrsUS$5.86m26.55%
$ 2.1b
Gerald Herman
Executive VP & CFO6.7yrsUS$2.20m0.033%
$ 2.6m
Mark Munch
Corporate Executive VP and President of Bruker Nano Group & Corporate9.3yrsUS$2.73m0.050%
$ 4.1m
Juergen Srega
President of Bruker CALID Group & Bruker Daltonics Division11.8yrsUS$1.47m0.081%
$ 6.6m
Falko Busse
President of Bruker BioSpin Group6.5yrsUS$1.35m0.016%
$ 1.3m
Justin Ward
Senior Director of Investor Relations & Corporate Developmentno data데이터 없음데이터 없음
J. Alldredge
General Counsel & Secretaryno data데이터 없음데이터 없음
Burkhard Prause
President and CEO of Bruker Energy & Supercon Technologies16.6yrsUS$967.91k0.0090%
$ 726.6k

10.6yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 관리: BRKR 의 관리팀은 노련하고 경험 (평균 재직 기간 10.6 년)입니다.


이사회 구성원

이름위치테뉴어보상소유권
Frank Laukien
Chairman33.8yrsUS$5.86m26.55%
$ 2.1b
John Ornell
Independent Director9.3yrsUS$241.01k0.014%
$ 1.1m
Robert Rosenthal
Independent Director9yrsUS$224.01k0.019%
$ 1.5m
Richard Packer
Independent Director17.5yrsUS$227.32k0.047%
$ 3.8m
William Linton
Independent Lead Director24.8yrsUS$231.01k0.022%
$ 1.8m
Adelene Perkins
Independent Director7.5yrsUS$224.01k0.013%
$ 1.0m
Hermann Requardt
Independent Director9.3yrsUS$219.01k0.014%
$ 1.1m
Bonnie Anderson
Independent Director4.2yrsUS$219.65k0.0050%
$ 408.6k
Cynthia Friend
Independent Director8.5yrsUS$216.83k0.0076%
$ 618.1k

9.3yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: BRKR 의 이사회경험(평균 재직 기간 9.3 년)으로 간주됩니다.